{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_181797.2:c.6056A>G",
          "cDNA Change": {
            "transcript": "NM_181797.2",
            "ref": "A",
            "alt": "G",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "p.G2019S (NM_181797.2:c.6056A>G)"
        },
        {
          "HGVS": "NM_181797.2:c.4322G>T",
          "cDNA Change": {
            "transcript": "NM_181797.2",
            "ref": "G",
            "alt": "T",
            "position": "4322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "p.R1441C (NM_181797.2:c.4322G>T)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005256"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using HEK293 cells expressing LRRK2 variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_181797.2:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased kinase activity observed in G2019S-expressing cells compared to wild-type."
        },
        {
          "Variant": "NM_181797.2:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "R1441C variant exhibited elevated kinase activity in HEK293 cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated in triplicate across three independent biological preparations."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 10% of wild-type levels.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity exceeding 20% of wild-type levels.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Kinase Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "LRRK2 variants were expressed in SH-SY5Y cells for kinase activity measurements."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_181797.2:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "G2019S variant demonstrated 40% increased kinase activity compared to wild-type in SH-SY5Y cells."
        },
        {
          "Variant": "NM_181797.2:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "R1441C variant showed 30% higher kinase activity in SH-SY5Y cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated in triplicate across three independent biological preparations."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Unpaired t-test with multiple comparisons correction."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 15% of wild-type levels.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity exceeding 25% of wild-type levels.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}